|
关注：1
2013-05-23 12:21
求翻译：FURTHER LEAD OPTIMIZATION LED TO THE IDENTIFICATION OF MKC-442 AS THE CLINICAL DRUG CANDIDATE,BUT MITSUBISHI KASEI CORPORATION,THE OWNERS OF THE COMPOUND,WERE CONCERNED ABOUT POSSIBLE DRUG RESISTANCE DEVELOPMENT是什么意思？ 待解决
 悬赏分：1
- 离问题结束还有
FURTHER LEAD OPTIMIZATION LED TO THE IDENTIFICATION OF MKC-442 AS THE CLINICAL DRUG CANDIDATE,BUT MITSUBISHI KASEI CORPORATION,THE OWNERS OF THE COMPOUND,WERE CONCERNED ABOUT POSSIBLE DRUG RESISTANCE DEVELOPMENT
问题补充： |
|
2013-05-23 12:21:38
正在翻译，请等待...
|
|
2013-05-23 12:23:18
进一步优化导致确定了铭基书院的C.2002年的临床候选药物,但三菱化成工业公司、业主的大院,则关注可能抵制药物发展
|
|
2013-05-23 12:24:58
进一步主角优化LED对MKC-442的证明作为CLINICAL DRUG CANDIDATE， BUT MITSUBISHI KASEI CORPORATION，化合物的所有者，关注可能的药物抵抗发展
|
|
2013-05-23 12:26:38
正在翻译，请等待...
|
|
2013-05-23 12:28:18
正在翻译，请等待...
|
湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区
